BJDX - Bluejay Diagnostics, Inc.

2
0.080   4.000%

Share volume: 5,986
Last Updated: 04-22-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$1.92
0.08
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 35%
Dept financing 28%
Liquidity 52%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.52%
1 Month
-0.50%
3 Months
143.90%
6 Months
-17.70%
1 Year
18.34%
2 Year
220.00%
Key data
Stock price
$2.00
P/E Ratio 
N/A
DAY RANGE
$1.91 - $2.01
EPS 
-$7.72
52 WEEK RANGE
$0.63 - $4.17
52 WEEK CHANGE
$21.95
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
2.97
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,592
AVERAGE 30 VOLUME 
$16,348
Company detail
CEO: Indranil Dey
Region: US
Website: bluejaydx.com
Employees: 9
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Bluejay Diagnostics, Inc. develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis.

Recent news